AVROBIO Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Okay. Welcome, everyone. My name is Gena Wang. I'm SMID-Cap biotech analyst at Barclays. In this special situation, I first wish everyone, stay healthy. And I would like to thank all the participants, investors, companies, especially our event team and corporate access team who made this virtual health care conference possible.
With that, I would like to introduce our first presenting company, AVROBIO. With us, we have Geoff MacKay, Chief Executive Officer; Chris Mason, Chief Scientific Officer. We also have Erik Ostrowski, sorry, I hope I pronounced your name right, and that was the Chief Financial Officer; Diana Escolar also with us from AVRO.
So with that, I hand over to you, guys.
Thank you, Gena. So hello, this is Geoff here, and I look very forward to sharing our recent progress with you. Before I begin -- let's just see. The slides are just a little slow.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |